Importantly, in the evaluation of clinical cases encompassed within the TCGA datasets, no cases were identified that exhibited RB loss within the HER2 intrinsic subtype of breast cancer (Figure 3D). The gene discussed is ERBB2; the disease is breast carcinoma.